Two-for-one Stroke Thrombectomy: A novel Dual DAC to enhance navigability, lumen size, aspiration efficiency, and persistent flow arrest in mechanical thrombectomy
二合一中风血栓切除术:一种新型双 DAC,可增强机械血栓切除术中的导航性、管腔尺寸、抽吸效率和持续流动停止
基本信息
- 批准号:10698538
- 负责人:
- 金额:$ 49.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-20 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdoptionAnatomic ModelsAnatomyAngiographyAnimal TestingAnimalsBackBlood VesselsBlood coagulationBrainCadaverCathetersCerebrovascular systemClinicalClinical DataCoagulation ProcessCommunitiesDevelopmentDevicesDiameterDimensionsDistalEmbolismEnsureEnvironmentEvaluationExcisionFreezingGoalsHemorrhageIn VitroIngestionInternal carotid artery structureIschemic StrokeLabelLibrariesManufacturerMechanicsMedicalMedical DeviceNeurologic DeficitNeurological outcomeOutcomePainPatient CarePatient-Focused OutcomesPatientsPerformancePhasePhysiciansPhysiologicalProceduresProcessRecoveryReportingResearchResearch PersonnelResistanceRetrievalRiskSiteSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchSpecific qualifier valueStentsStrokeSuctionSystemTechniquesTechnologyTestingThickThinnessThrombectomyTimeTrainingVascularizationWidthWomanaspiratecombinatorialcommercializationcomparativedesignfallsflexibilityimprovedin vivoin vivo evaluationinnovationintracranial arterymiddle cerebral arteryneurovascularnext generationnovelporcine modelprogramsprototypereplicatorresponsestandard of carestroke interventionsuccess
项目摘要
PROJECT SUMMARY/ABSTRACT
The long-term goal of this proposal is to improve the care of patients suffering from Large Vessel Occlusion
Acute Ischemic stroke. Currently, mechanical thrombectomy techniques can achieve revascularization in over
70% of cases, and physicians are rapidly adoption aspiration thrombectomy over stent-trievers. Aspiration
maintains equivalent angiographic and clinical outcomes to stent-retrieval, but larger catheters and new
combinatorial techniques have given rise to promises of faster, cheaper, more effective “Super Bore” devices.
The way to improve aspiration technologies is to expand the inner diameter (ID) of distal access catheters
(DACs): in vitro studies have shown that catheters with ID of 0.088” have near-perfect rates of clot ingestion in
a single pass, spurring development of multiple Super Bore 088 DAC systems. While the enthusiasm for the
088DACs remains extremely high among the interventional stroke community, limitations in recent clinical
reports point to key aspects that could readily be improved with novel design features. First, a “one-size- fits-
all” approach may not be ideal for many patients, especially women with smaller intracranial arteries.
Specifically, the middle cerebral artery (MCA), where most clots reside, has variable width. Second, the
promise of “localized flow arrest” with the large bore catheters, where the catheter itself is large enough to stop
forward flow, falls apart if the clot is not ingested immediately and “corked” clots as the tip must be pulled into
the guiding catheter, risking downstream emboli. Third, the 0.088” ID is still too small for clots that lodge in the
internal carotid artery. Finally, most of the currently proposed 088DACs are incompatible with 8Fr access
sheaths, and thus cannot be used on-label with arterial closure devices, increasing the risk of hemorrhage.
In response to these challenges, we have designed a novel, two-component, telescoping “Dual DAC” system
that, as a unit, has the same ID of other “Super Bore” DACs while achieving 8Fr short sheath compatibility.
The inner DAC provides the target 0.088” ID, yet fits into the outer DAC’s 0.101”ID. By thinning the walls of the
two nested DACs, we provide all of the performance features, and much more, of the other Super Bore 088
DACs. Our system can be placed in the MCA, but instead of a single, thick-walled 0.088” catheter, our system
allows placement of both DACs simultaneously in most patients. The inner DAC is used for aspiration, while
the outer DAC remains in the MCA for persistent local flow arrest during retrieval of the inner DAC. Further,
our inner DAC, with an OD almost 1Fr smaller than other Super Bore 088 DACs, will fit even into narrow MCAs
in smaller women. To date, we have constructed prototypes and demonstrated outstanding trackability of the
Dual DAC system in leading neurovascular simulators. In this Phase 1 STTR we propose to refine and test the
system to achieve design freeze. If successful, this research program will provide the next generation system
for clot ingestion, which we will drive forward to commercialization through GLP animal and other testing
required to achieve regulatory clearance in our Phase II.
项目总结/摘要
该提案的长期目标是改善大血管闭塞患者的护理
急性缺血性中风。目前,机械血栓切除术技术可以在超过10年的时间内实现血运重建。
70%的病例,医生正在迅速采用抽吸血栓切除术而不是支架取出器。抽吸
保持与支架回收等同的血管造影和临床结果,但导管更大且新
组合技术已经产生了更快、更便宜、更有效的“超级孔”装置的希望。
改进抽吸技术的方法是扩大远端通路导管的内径(ID)
(DAC):体外研究表明,ID为0.088”的导管在体内具有近乎完美的凝块摄取率。
单次通过,刺激了多个Super Bore 088 DAC系统的开发。虽然对
088 DAC在介入性卒中人群中仍然非常高,
报告指出了可以通过新颖的设计特征容易地改进的关键方面。第一,“一刀切"--
对于许多患者,尤其是颅内动脉较小的女性患者,“All”入路可能并不理想。
具体来说,大多数凝块所在的大脑中动脉(MCA)具有可变的宽度。二是
大口径导管有望实现“局部血流停止”,导管本身足够大,
前向流,如果凝块没有立即摄入,则福尔斯会分开,并且由于必须将尖端拉入,因此会形成“软木塞”凝块
引导导管,有下游栓塞的风险。第三,0.088”的ID对于留在血管中的凝块来说仍然太小。
颈内动脉最后,目前提出的大多数088 DAC与8 Fr接入不兼容
鞘管,因此不能按标签与动脉闭合器械一起使用,增加了出血风险。
为了应对这些挑战,我们设计了一种新颖的,两个组件,伸缩“双DAC”系统
作为一个单元,具有与其他“Super Bore”DAC相同的ID,同时实现8 Fr短护套兼容性。
内部DAC提供目标0.088”ID,但适合外部DAC的0.101“ID。
两个嵌套DAC,我们提供了其他Super Bore 088的所有性能特性,甚至更多
DAC。我们的系统可以放置在MCA中,但不是单个厚壁0.088”导管,我们的系统
允许在大多数患者中同时放置两个DAC。内部DAC用于抽吸,而
外部DAC保留在MCA中,用于在收回内部DAC期间持续的局部血流停止。此外,本发明还
我们的内部DAC的OD比其他Super Bore 088 DAC小近1 Fr,甚至可以装入窄MCA
在较小的女人。到目前为止,我们已经构建了原型,并展示了出色的可跟踪性,
领先的神经血管模拟器中的双DAC系统。在第1阶段STTR中,我们建议完善和测试
系统实现设计冻结。如果成功,该研究计划将提供下一代系统
对于凝块摄入,我们将通过GLP动物和其他测试推动其商业化
在我们的第二阶段获得监管许可。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID F KALLMES其他文献
DAVID F KALLMES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID F KALLMES', 18)}}的其他基金
Harnessing the latent heat of saline evaporation for safe and effective endovascular therapeutic organ cooling
利用盐水蒸发的潜热进行安全有效的血管内治疗器官冷却
- 批准号:
10739142 - 财政年份:2023
- 资助金额:
$ 49.98万 - 项目类别:
Enabling rapid and effective stroke thrombectomy procedures from a Transradial approach: Combining introducer sheath, guide catheter, and distal access catheter into a single device.
通过经桡动脉途径实现快速有效的中风血栓切除术:将导引鞘、引导导管和远端通路导管组合到单个设备中。
- 批准号:
10254745 - 财政年份:2021
- 资助金额:
$ 49.98万 - 项目类别:
Simplified Transfemoral Carotid Angioplasty and Stenting Under FlowReversal Using a Novel Combination Access Sheath/Balloon System
使用新型组合通路鞘/球囊系统在血流逆转下简化经股颈动脉血管成形术和支架置入术
- 批准号:
10081007 - 财政年份:2020
- 资助金额:
$ 49.98万 - 项目类别:
Development of Intrasaccular Flow Disrupters for Small and Ruptured Aneurysms
针对小动脉瘤和破裂动脉瘤的囊内血流干扰器的开发
- 批准号:
9136473 - 财政年份:2016
- 资助金额:
$ 49.98万 - 项目类别:
Translational, multimodality correlation between human and rabbit saccular aneurysms
人和兔囊状动脉瘤之间的转化、多模态相关性
- 批准号:
8995704 - 财政年份:2015
- 资助金额:
$ 49.98万 - 项目类别:
Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms
治疗颅内动脉瘤的新型血流转向支架的临床前测试
- 批准号:
9229076 - 财政年份:2011
- 资助金额:
$ 49.98万 - 项目类别:
Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms
治疗颅内动脉瘤的新型血流转向支架的临床前测试
- 批准号:
9046467 - 财政年份:2011
- 资助金额:
$ 49.98万 - 项目类别:
Development of a second generation intra-sacular cerebral aneurysm flow diverter
第二代囊内脑动脉瘤分流器的研制
- 批准号:
8124767 - 财政年份:2011
- 资助金额:
$ 49.98万 - 项目类别:
SHAM-CONTROLLED TRIAL OF PERCUTANEOUS VERTEBROPLASTY
经皮椎体成形术的假手术对照试验
- 批准号:
6908267 - 财政年份:2002
- 资助金额:
$ 49.98万 - 项目类别:
SHAM-CONTROLLED TRIAL OF PERCUTANEOUS VERTEBROPLASTY
经皮椎体成形术的假手术对照试验
- 批准号:
6668655 - 财政年份:2002
- 资助金额:
$ 49.98万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 49.98万 - 项目类别:
Research Grant